Monopar Therapeutics Inc. Banner Image

Monopar Therapeutics Inc.

  • Ticker MNPR
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Monopar Therapeutics Inc. Logo Image
  • 1-10 Employees
  • Based in Wilmette, Illinois
Monopar Therapeutics is a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. Monopar's pipeline consists of Validive® for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients; camsirubicin for the treatment of advanced softMore tissue sarcoma; and a late-stage preclinical antibody, MNPR-101, for advanced cancers and severe COVID-19.
4.7 / 5.0 (168)

Monopar Therapeutics Inc. reports have an aggregate usefulness score of 4.7 based on 168 reviews.

Monopar Therapeutics Inc.

Most Recent Annual Report

Monopar Therapeutics Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Monopar Therapeutics Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!